CO2021018071A2 - Cápsulas de gelatina blanda de liberación retardada - Google Patents

Cápsulas de gelatina blanda de liberación retardada

Info

Publication number
CO2021018071A2
CO2021018071A2 CONC2021/0018071A CO2021018071A CO2021018071A2 CO 2021018071 A2 CO2021018071 A2 CO 2021018071A2 CO 2021018071 A CO2021018071 A CO 2021018071A CO 2021018071 A2 CO2021018071 A2 CO 2021018071A2
Authority
CO
Colombia
Prior art keywords
delayed release
soft gelatin
gelatin capsules
release soft
dependent
Prior art date
Application number
CONC2021/0018071A
Other languages
English (en)
Inventor
Qi Fang
Karunakar Sukuru
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2021018071A2 publication Critical patent/CO2021018071A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

Las cápsulas de gelatina blanda de liberación retardada comprenden un material de relleno y una composición de cubierta dependiente del pH, caracterizada porque la naturaleza de liberación retardada de las cápsulas puede lograrse sin un recubrimiento dependiente del pH o sin añadir polímeros convencionales dependientes del pH.
CONC2021/0018071A 2019-06-03 2021-12-29 Cápsulas de gelatina blanda de liberación retardada CO2021018071A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962856601P 2019-06-03 2019-06-03
PCT/US2020/035666 WO2020247352A1 (en) 2019-06-03 2020-06-02 Delayed release softgel capsules

Publications (1)

Publication Number Publication Date
CO2021018071A2 true CO2021018071A2 (es) 2022-04-19

Family

ID=73652472

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0018071A CO2021018071A2 (es) 2019-06-03 2021-12-29 Cápsulas de gelatina blanda de liberación retardada

Country Status (14)

Country Link
US (1) US20220354800A1 (es)
EP (1) EP3976022A4 (es)
JP (1) JP7558204B2 (es)
KR (1) KR20220024189A (es)
CN (1) CN114072138A (es)
AR (1) AR119075A1 (es)
AU (1) AU2020288165A1 (es)
BR (1) BR112021024375A2 (es)
CA (1) CA3142702A1 (es)
CO (1) CO2021018071A2 (es)
IL (1) IL288653A (es)
MX (1) MX2021014922A (es)
TW (1) TW202110426A (es)
WO (1) WO2020247352A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230404926A1 (en) * 2020-11-11 2023-12-21 R.P. Scherer Technologies, Llc Delayed release softgel capsules
US20240189241A1 (en) * 2021-04-01 2024-06-13 R.P. Scherer Technologies, Llc Phospholipids as anion chelating agents in pharmaceutical formulations
EP4366709A1 (en) * 2021-07-06 2024-05-15 R.P. Scherer Technologies, LLC Softgel capsule
WO2023158777A1 (en) * 2022-02-18 2023-08-24 R.P. Scherer Technologies, Llc Modified release valproic acid softgel capsule
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung
US20240165041A1 (en) * 2022-11-23 2024-05-23 R.P. Scherer Technologies, Llc Softgel Capsule and Method of Marking a Softgel Capsule

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003043609A1 (fr) * 2001-11-22 2003-05-30 Morishita Jintan Co., Ltd. Compositions de film pour capsules non gelatineuses et capsules utilisant celles-ci
EP1572164A2 (en) * 2002-12-18 2005-09-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
CN101292965B (zh) 2007-04-24 2011-12-07 沈阳皓天万嘉医药科技有限公司 一种类β-胡萝卜素微囊及其制备方法
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
EP2461797A4 (en) * 2009-08-05 2014-04-16 7267207 Canada Ltd Corp PROCESS FOR THE PREPARATION FOR FREE SALE OF A GELATIN OR PEPTINE MEDICAMENT
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
WO2013093630A2 (en) * 2011-12-22 2013-06-27 Pronova Biopharma Norge As Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
CA2896864C (en) * 2013-01-05 2021-04-20 Elcelyx Therapeutics, Inc. Delayed-release composition comprising biguanide
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
JP6243057B2 (ja) * 2014-10-06 2017-12-06 富士カプセル株式会社 腸溶性シームレスソフトカプセルの製造方法
CN104644609B (zh) 2015-01-28 2017-06-16 龙标兵 一种功能性咀嚼型软胶囊皮
US20170119680A1 (en) 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
CN108578381A (zh) * 2018-02-27 2018-09-28 广州彤博士健康科技有限公司 可咀嚼性软胶囊外皮的配方及制备方法

Also Published As

Publication number Publication date
CA3142702A1 (en) 2020-12-10
JP7558204B2 (ja) 2024-09-30
CN114072138A (zh) 2022-02-18
AU2020288165A1 (en) 2022-01-06
EP3976022A1 (en) 2022-04-06
BR112021024375A2 (pt) 2022-04-19
AR119075A1 (es) 2021-11-24
IL288653A (en) 2022-02-01
EP3976022A4 (en) 2023-06-14
JP2022535539A (ja) 2022-08-09
US20220354800A1 (en) 2022-11-10
MX2021014922A (es) 2022-03-11
WO2020247352A1 (en) 2020-12-10
TW202110426A (zh) 2021-03-16
KR20220024189A (ko) 2022-03-03

Similar Documents

Publication Publication Date Title
CO2021018071A2 (es) Cápsulas de gelatina blanda de liberación retardada
CO2020011451A2 (es) Capsulas entericas de gel blando
ZA202005153B (en) Enteric softgel capsules
JOP20170055B1 (ar) تركيبة شراب تحتوي على اليولوز وطعام يحتوي على التركيبة
SG11201911961RA (en) Methods of encapsulating single cells, the encapsulated cells and uses thereof
HUE059621T2 (hu) Vízoldható film, a filmet hasznosító csomagolások, és eljárások ezek elõállítására és használatára
AR108920A1 (es) Partículas y composiciones de nicotina
IL282320A (en) Protoantigen-representing synthetic surfaces, activated T-cells and their uses
CO2022019321A2 (es) Cápsulas de gel de liberación retardada
CO2022007168A2 (es) Cápsulas de gelatina blanda de liberación retardada en ambientes de ph más alto
ECSP19072372A (es) Moduladores de la expresión de pcsk9
CA181437S (en) Capsule
CY1123908T1 (el) Δισκιο με εντερικη επικαληψη
CA173257S (en) Packaging base
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
WO2019213606A3 (en) Solid forms of cerdulatinib
WO2017021855A3 (en) Motile sperm domain containing protein 2 and inflammation
AR117223A1 (es) Aparato y proceso para el encapsulado secundario de inclusiones sólidas utilizando el proceso de matriz rotativa
EA201792609A1 (ru) Протез связки
MD4877B1 (ro) Compoziţie farmaceutică şi comprimat oral de S-adenozilmetionină cu eliberare întârziată
MY197879A (en) Pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa
CL2018002462A1 (es) Composiciones farmacéuticas disuasivas del abuso.
AU201814306S (en) In-wall line array speaker
MX2020000104A (es) Gránulos tabletas estables y en ambiente de agua.
UA122220U (uk) Капсула для м'якого сиру